Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial

Supportive Care in Cancer

Volumn 12, Issue 9, 2004, Pages 640-644

  Jatoi, Aminah ^a   Egner, James ^b   Loprinzi, Charles L ^a   Sloan, Jeff A ^a   Novotny, Paul J ^a   Dakhil, Shaker R ^c   Mailliard, James A ^d   Klee, George G ^a   Krook, James E ^e  

^a MAYO CLINIC   (United States)

^b Carle Cancer Center CCOP   (United States)

^c Cancer Center of Kansas   (United States)

^d MISSOURI VALLEY CANCER CONSORTIUM   (United States)

^e Duluth Community Clinical Oncology Program   (United States)

Author keywords

Cancer anorexia weight loss syndrome; Cytokines; Interleukin 1 beta; Interleukin 6; Tumor necrosis factor alpha

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANOREXIA; APPETITE; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CANCER; CANCER RISK; CLINICAL TRIAL; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; WEIGHT REDUCTION;

AGED; ANOREXIA; APPETITE; CACHEXIA; CYTOKINES; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MEGESTROL ACETATE; NEOPLASMS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4644301742     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-004-0624-3     Document Type: Article

References (25)

1. Jatoi A, Loprinzi CL (2001) Current management of cancer-associated anorexia and weight loss. Oncology (Huntingt) 4:497-502
2. Torelli GF, Meguid MM, Moldawer LL, et al (1999) Use of recombinant human soluble TNF receptor in tumor-bearing animals. Am J Physiol 277 (3 Pt 2):R850-855
3. Josephs MD, Solarzano CC, Taylor M, et al (2000) Modulation of the acute phase response by altered expression on the IL-1 type 1 receptor or IL-1ra. Am J Physiol Regul Integr Comp Physiol 278:R824-R830
4. Cahlin C, Axelsson KH, Wang W, et al (2000) Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 B1 background and eicosanoid-dependent cachexia. Cancer Res 60:5488-5493
5. Molotkov A, Satoh M, Tohyama C (1998) Tumor growth and food intake in interleukin-6 gene knockout mice. Cancer Lett 132:187-192
6. Mantovani G, Maccio A, Mura L, et al (2000) Serum levels of leptin and proinflammatory cytokines in patients with advanced stage cancer at different sites. J Mol Med 78:554-561
7. Mantovani G, Maccio A, Lai P, et al (1998) Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Semin Oncol 25 [Suppl 6]:45-52
8. Maltoni M, Fabbri L, Nanni O, et al (1997) Serum levels of tumor necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients. Support Care Cancer 5:130-135
9. Jatoi A, Rowland K, Loprinzi CL, et al (2003) An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a collaborative effort from the North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. Proc Am Soc Clin Oncol, abstract 2987
10. Jatoi A, Windschitl HE, Loprinzi CL, et al (2002) Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 20:567-573
11. Loprinzi CL, Ellison NM, Schaid DJ, et al (1990) Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 82:1127-1132
12. Pfitzenmaier J, Vessella R, Higano CS, et al (2003) Elevation of cytokine levels in cachectic patients with prostate carcinoma. Cancer 97:1211-1216
13. Oymak Y, Velioglu A, Haklar G, et al (2003) Early detection of peritonitis in continuous ambulatory peritoneal dialysis patients by cytokine measurements. Clin Chem Lab Med 41:640-645
14. Senturk T, Kozaci LD, Kok F, et al (2003) Proinflammatory cytokine levels in hyperthyroidism. Clin Invest Med 26:58-63
15. Conover WJ (1980) Practical nonparametric statistics, 2nd edn. Wiley, New York
16. Cox DR (1981) Regression models and life-tables. J R Soc Series 8 34:187-220
17. Stevens J (1990) Intermediate statistics: a modern approach. Lawrence Erlbaum Associates, Hillsdale, NJ
18. Agteresch HJ, Dagnalie PC, van der Gaast A, et al (2000) Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small cell lung cancer. J Natl Cancer Inst 92:321-328
19. Bruera E, Strasser F, Palmer JL, et al (2003) Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind placebo-controlled study. J Clin Oncol 21:129-134
20. Bachelot T, Ray-Coquard I, Menetrier-Caux C, et al (2003) Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer 88:1721-1726
21. Lai R, O'Brien S, Maushouri T, et al (2002) Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia. Cancer 95:1071-1075
22. Niitsu N, Okamato M, Nakamine H, et al (2002) Simultaneous elevation of serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma. Eur J Haematol 68:91-100
23. Andrews B, Shariat SF, Kim JH, et al (2002) Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. J Urol 167:1475-1481
24. Nakashima J, Tachibana M, Horiguchi Y, et al (2000) Serum interleukin-6 as a prognostic factor in patients with prostate cancer. Clin Cancer Res 6:2702-2706
25. Belluco C, Nitti D, Frantz M, et al (2000) Interleukin-6 blood levels is associated with circulating carcinoembryonic antigen and prognosis with colorectal cancer. Ann Surg Oncol 7:133-138